Mapping peptide antagonist binding sites of the human V1a and V2 vasopressin receptors

Advances in Experimental Medicine and Biology

Volumn 449, Issue , 1998, Pages 359-361

  Mouillac, B ^a   Phalipou, S ^a   Cotte, N ^a   Balestre, M N ^a   Hibert, M ^b   Manning, M ^c   Barberis, C ^a  

^a CCIPE   (France)

^b SANOFI   (France)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; OXYTOCIN RECEPTOR; RECEPTOR SUBTYPE; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ANIMAL CELL; CELL STRAIN COS1; CHO CELL; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PEPTIDE MAPPING; PHOTOACTIVATION; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; RAT; REVIEW; SEQUENCE HOMOLOGY;

ANIMALIA;

EID: 0031678376     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4871-3_45     Document Type: Review

References (4)

1. Mouillac B, Chini B, Balestre MN, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Jard S, Barberis C 1995. The binding site of neuropeptide vasopressin V1a receptor: evidence for a major localization within transmembrane regions. J Biol Chem 270: 25771-25777.
2. Chini B, Mouillac B, Ala Y, Balestre MN, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, Jard S, Barberis C 1995. Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO J 14: 2176-2182.
3. Carnazzi E, Aumelas A, Barberis C, Guillon G, Seyer R 1994. A new series of photoactivatable and iodinatable linear vasopressin antagonists. J Med Chem 37: 1841-1849.
4. Phalipou S, Cotte N, Carnazzi E, Seyer R, Mahe E, Jard S, Barberis C, Mouillac B 1997. Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonist. J Biol Chem 272: 26536-26544.